Evidence map›Paper›PMID 42014700›Full record

ArticleNature communications2026

Loss of DNA methyltransferase 3a enhances Caspase-8 transcription and promotes cardiomyocyte pyroptosis during myocardial infarction.

Ning Wang, Liling Gong, Xingmiao Zhao, Wenshuang Zhao, Ning Xu, Ximing Chen, Qingwei Zhang, Ming Li, Yijing Yao, Hang Yu and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ning Wang *Department of Pharmacy at The Second Affiliated Hospital, Harbin Medical University, Harbin, China. wangning@ems.hrbmu.edu.cn.
Liling Gong *Department of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Xingmiao ZhaoDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Wenshuang ZhaoDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Ning XuDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Ximing ChenDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Qingwei ZhangNHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Harbin, China.
Ming LiDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Yijing YaoDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Hang YuDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Qingsui LiDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Zhen ZhangDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Liwei ZhuDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Long QinDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Xu SuDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Zhen ZhangDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Wei LiDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Wanyu ZhangDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Yadong XueDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Xianzhi LangDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Pengyu LiDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Sijia LiDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Siyu ChangDepartment of Pharmacology at College of Pharmacy, Harbin Medical University, Harbin, China.
Jiamin LiDepartment of Pharmacy at The Second Affiliated Hospital, Harbin Medical University, Harbin, China. lijiamin0616@163.com.ORCID http://orcid.org/0009-0009-2846-6711
Benzhi CaiDepartment of Pharmacy at The Second Affiliated Hospital, Harbin Medical University, Harbin, China. caibenzhi@163.com.ORCID http://orcid.org/0000-0003-0017-867X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82170284National Natural Science Foundation of China (National Science Foundation of China) 82370328National Natural Science Foundation of China (National Science Foundation of China) 82470326National Natural Science Foundation of China (National Science Foundation of China) 82570382National Natural Science Foundation of China (National Science Foundation of China) 92468301National Natural Science Foundation of China (National Science Foundation of China) U25A20184Natural Science Foundation of Heilongjiang Province ZD2023H001
6 · The paper itself

Abstract

Aspartate-specific cysteine protease (Caspase)-8 plays a critical role in initiating pyroptosis by mediating cleavage and activation of gasdermin-D (Gsdmd) during Yersinia infection. However, the role of Caspase-8 in pyroptosis after myocardial infarction (MI) and its underlying mechanism remains elusive. Here we show that Caspase-8 is essential for cardiomyocyte pyroptosis post MI and Caspase-8/Gsdmd signaling pathway is activated in hearts of male infarcted mice. The inhibition of Caspase-8 in male mice rescues the decline of cardiac function and cardiomyocyte pyroptosis following MI. Dnmt3a is further shown to impact DNA methylation on the CpG island of Caspase-8 promoter and regulate Caspase-8 expression. Dnmt3a overexpression protects myocardium from MI in male mice by inhibiting cardiomyocyte pyroptosis. Moreover, reduction of Dnmt3a in MI is attributed to the increased ubiquitination. Our study identifies a regulatory axis, Dnmt3a/Caspase-8/Gsdmd, which drives ischemic heart injury by promoting cardiomyocyte pyroptosis, and suggests potential therapeutic targets for heart diseases.

Indexed as

Caspase 8DNA (Cytosine-5-)-MethyltransferasesMyocardial InfarctionMyocytes, CardiacPyroptosisAnimalsCpG IslandsDNA MethylationDNA Methyltransferase 3AGasderminsHumansMaleMiceMice, Inbred C57BLMyocardiumPhosphate-Binding ProteinsCasp8 protein, mouseCaspase 8DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADnmt3a protein, mouseGasderminsGsdmd protein, mousePhosphate-Binding ProteinsPore Forming Cytotoxic Proteins

Identifiers

PMID42014700
PMCPMC13287685

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.